Advertisement

Topics

French Biotech Starts Trials to Restore Sight in All Types of Retinitis Pigmentosa

07:48 EST 10 Jan 2018 | Labiotech.eu

GenSight will start a clinical trial in the UK testing a combination of gene therapy and a wearable device to restore sight in patients with retinitis pigmentosa.  The UK Medicines and Healthcare Regulatory Agency (MHRA) has accepted GenSight’s application to run ...

This awesome article French Biotech Starts Trials to Restore Sight in All Types of Retinitis Pigmentosa appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: French Biotech Starts Trials to Restore Sight in All Types of Retinitis Pigmentosa

NEXT ARTICLE

More From BioPortfolio on "French Biotech Starts Trials to Restore Sight in All Types of Retinitis Pigmentosa"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...